Upgrade to SI Premium - Free Trial

Dyadic International, Inc. (DYAI)

0.40 +0.01 (2.56%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form SCHEDULE 13G DYADIC INTERNATIONAL Filed by: Empery Asset Management, LP October 15, 2026 12:29 PM - SEC Filing Form 8-K DYADIC INTERNATIONAL For: Sep 25 September 25, 2026 5:27 PM - SEC Filing Form EFFECT DYADIC INTERNATIONAL September 21, 2026 6:09 AM - SEC Filing Form 424B3 DYADIC INTERNATIONAL September 18, 2026 5:29 PM - SEC Filing Form S-1 DYADIC INTERNATIONAL September 11, 2026 5:28 PM - SEC Filing Q3 Virtual Investor Summit Presentations Now Available On Demand August 31, 2026 6:16 PM - StreetInsider Form SCHEDULE 13G/A DYADIC INTERNATIONAL Filed by: Francisco Trust under agreement dated February 28, 1996 August 17, 2026 9:25 AM - SEC Filing Form 8-K DYADIC INTERNATIONAL For: Aug 13 August 14, 2026 9:18 AM - SEC Filing Form 424B5 DYADIC INTERNATIONAL August 13, 2026 5:25 PM - SEC Filing Dyadic International (DYAI) PT Lowered to $4 at Craig-Hallum August 13, 2026 9:19 AM - StreetInsider Dyadic International raises $2.9M via stock offering and warrants August 13, 2026 8:00 AM - StreetInsider Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement  August 13, 2026 8:00 AM - StreetInsider Form 10-Q DYADIC INTERNATIONAL For: Jun 30 August 12, 2026 8:46 AM - SEC Filing Form 8-K DYADIC INTERNATIONAL For: Aug 12 August 12, 2026 8:46 AM - SEC Filing Dyadic International, Inc. (DYAI) Misses Q2 EPS by 2c August 12, 2026 8:33 AM - StreetInsider Dyadic posts wider Q2 loss as costs rise despite flat revenue August 12, 2026 8:32 AM - StreetInsider Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas August 12, 2026 8:30 AM - Globe NewsWire Dyadic signs new dairy protein deal with European biotech firm August 4, 2026 7:28 AM - StreetInsider Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement August 4, 2026 7:25 AM - StreetInsider Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 August 3, 2026 4:30 PM - StreetInsider Form 144 DYADIC INTERNATIONAL Filed by: Francisco Trust under agreement dated February 28, 1996 July 29, 2026 3:46 PM - SEC Filing Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days July 28, 2026 8:30 AM - StreetInsider Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days July 28, 2026 8:30 AM - StreetInsider Form 4 DYADIC INTERNATIONAL For: Jul 22 Filed by: Francisco Trust under agreement dated February 28, 1996 July 24, 2026 5:11 PM - SEC Filing Form 8-K DYADIC INTERNATIONAL For: Jul 24 July 24, 2026 8:00 AM - SEC Filing Dyadic regains Nasdaq compliance, stock to remain listed July 24, 2026 7:30 AM - StreetInsider Dyadic Announces Continued Listing on the Nasdaq Capital Market July 24, 2026 7:30 AM - StreetInsider Full Article List